Schedule 13D ownership disclosure
HISTOGENICS CORP
Security class unavailable · CUSIP: 43358V109
Event date: 2016-12-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,166,382
- Percent of class
- 19.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-17-006058
- Form type
- SC 13D
- Filer
- Ocugen, Inc.
- CIK
- CIK 1372299
- Filed
- Feb 02, 2017
- Reporting period
- Dec 13, 2016
- Description
- Schedule 13D beneficial ownership